ATC code None CAS Number 251565-85-2 UNII 6734037O3L Molar mass 408.46 g/mol ChEMBL ID 521632 | Legal status Development terminated PubChem CID 208901 KEGG D01274 Pubchem 208901 ChemSpider ID 180999 | |
 | ||
How to pronounce tesaglitazar
Tesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
The drug had completed several phase III clinical trials, however in May, 2006 AstraZeneca announced that it had discontinued further development.
References
Tesaglitazar Wikipedia(Text) CC BY-SA